Drug intelligence / Profile preview

1+1 hydromorphone protocol

Development stage
Unknown
Lead developer
Montefiore Medical Center
Modality
Small Molecules
Administration
Intravenous
01

Overview

The 1+1 protocol is a patient-driven intravenous hydromorphone titration strategy developed by researchers at Montefiore Medical Center for the management of acute severe pain in emergency department patients. The protocol involves an initial 1 mg dose of IV hydromorphone, followed by a mandatory assessment 15 minutes later. At this interval, the patient is asked, "Do you want more pain medication?" If the patient answers "yes," a second 1 mg dose is administered. This approach is designed to provide efficacious analgesia while allowing for individual variation in opioid requirements and minimizing the risk of over-sedation or respiratory depression. It has been studied in Phase 3 clinical trials, comparing its efficacy and safety against fixed-dose bolus regimens (such as 2 mg IV hydromorphone) and traditional physician-directed care.

Other names
1+1 protocol1 + 1-Montefiore Medical Center-acute painMontefiore 1+1 protocolpatient-driven titration protocol
02

Targets

CNR1 (Cannabinoid receptor 1)SIGMAR1 (Sigma non-opioid intracellular receptor 1)MOR (Mu opioid receptor)DOR (Opioid Receptor Delta 1)KOR (Kappa opioid receptor)

Beyond the preview

Go deeper on 1+1 hydromorphone protocol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1+1 hydromorphone protocol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call